PARIS & TARRYTOWN, N.Y. -- Sanofi-aventis (Euronext: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today provided an update on the clinical development program for aflibercept, including results from a Phase 2 study in advanced ovarian cancer.
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c67610) has announced the addition of Sanofi-Aventis Dealmaking Profile 2007 to their offering.
Attorney Advertising. Notice is hereby given that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Sanofi-Aventis ("Sanofi" or the "Company") (NYSE: SNY) publicly traded stock or American Depository Receipts ("ADRs") between February 17,...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c56767) has announced the addition of "Sanofi-Aventis Company Profile" to their offering.
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c60257) has announced the addition of Datamonitor's new report: Sanofi-Aventis - SWOT Analysis to their offering.
CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Jason Napodano, who discusses Pfizer (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), Sanofi-Aventis (NYSE: SNY) and Merck (NYSE: MRK).
NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel cancer therapeutics, today announced that it has signed a settlement agreement with Yeda Research and Development Company Ltd. and Sanofi-Aventis to end worldwide litigation related to U.S. Patent No. 6,217,866 (the "866...
Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of the publicly traded stock or American Depository Receipts ADRs of Sanofi-Aventis ("Sanofi" or the "Company") (NYSE: SNY) between...
NEW YORK -- Coughlin Stoia Geller Rudman & Robbins LLP ("Coughlin Stoia") (http://www.csgrr.com/cases/sanofi/) today announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the Southern District of New York on behalf of purchasers of Sanofi-Aventis ("Sanofi" or the...
On November 13, 2007, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Sanofi-Aventis (NYSE: SNY). The complaint alleges violations of federal securities laws, Sections 10b and 20a of the Securities Exchange Act of 1934 and Rule 10b-5,...
IN AN EVER-changing marketplace, pharma marketers must always be working on ways to foster patient relationships, according to the marketing VP behind Sanofi-Aventis' blockbuster Ambien CR.
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c44038) has announced the addition of the latest title from Datamonitor "Sanofi-Aventis: PharmaVitae Profile" to their offering.
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c26245) has announced the addition of Sanofi-Aventis Deals Briefing to their offering.
SANOFI-AVENTIS MOVED ITS OPERATIONS and about 2,000 employees to its sprawling new facility in Bridgewater, NJ. Gov. John Corzine right paid a visit to the company in March during a ribbon-cutting ceremony to congratulate global Chairman JeanFrancois Dehecq left on the move. The ISO-acre campus houses all US Pharmaceutical Operations...
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
Choose up to 5" more legroom with Economy Plus. Starting at $14.
Innovative USB Sleep'n Charge. Stylish Fusion™ finish. Ultra-portable. It's clear why the Satellite® U405 is a smart choice for you and your small business. Only from the laptop expert, Toshiba.
